Found: 5
Select item for more details and to access through your institution.
Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects.
- Published in:
- Therapeutic Advances in Drug Safety, 2023, v. 14, p. 1, doi. 10.1177/20420986231213173
- By:
- Publication type:
- Article
Safety of Repeated Administration of Parenteral Ketamine for Depression.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 7, p. 151, doi. 10.3390/ph13070151
- By:
- Publication type:
- Article
Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
- Published in:
- American Journal of Health-System Pharmacy, 2021, v. 78, n. 7, p. 613, doi. 10.1093/ajhp/zxab003
- By:
- Publication type:
- Article
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
- Published in:
- Harm Reduction Journal, 2022, v. 19, n. 1, p. 1, doi. 10.1186/s12954-022-00651-3
- By:
- Publication type:
- Article
Prevalence and distribution of high‐risk prescription opioid use in the United States, 2011–2016.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 11, p. 1532, doi. 10.1002/pds.5349
- By:
- Publication type:
- Article